Positive results of heterogeneous implementation of continuous glucose monitoring in Spain

Granada, home of Spain’s largest scientific conference of the year on diabetes

The interdisciplinary nature of this meeting makes it a reference meeting that presents promising scientific advances, especially in the field of slowing the onset of type 1 diabetes and controlling type 2 diabetes, without leaving aside the emotional aspects of people with diabetes. + read more

Metabolomics and machine learning can help predict early signs of type 2 diabetes

The study combined nuclear magnetic resonance-based metabolomics and machine learning to find a glucose-independent molecular signature associated with T2DM. + read more

FreeStyle Libre technology^® and GLP-1 drugs work best in combination for type 2 diabetes.

FreeStyle Libre technology^® from @AbbottNews and GLP-1 drugs work better together for type 2 diabetes + more

SEN Congress: New diabetes treatments are safe for kidney transplant patients

This is the first multicenter study conducted in this regard: none of the 96 patients observed experienced episodes of acute rejection or development of donor-specific antibodies. + read more

Pancreas transplantation also for T2DM?

There is a percentage of patients with type 2 diabetes with end-stage renal disease who may benefit from a pancreas transplant. + read more

Benefits of maintaining intensive glucose control after an initial diagnosis of type 2 diabetes

Intensive glucose control after initial diagnosis of type 2 diabetes significantly reduces the risk of developing microvascular complications such as retinopathy, chronic kidney disease, or neuropathy. + read more